Retatrutide 30mg Smartpen

Retatrutide 30mg Smartpen
£120.00

Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide in its class. It builds on the progress of earlier compounds like Semaglutide and Tirzepatide by activating three key hormonal pathways involved in appetite regulation, glucose control, and fat metabolism.

This enhanced activity leads to faster, more dramatic fat loss while offering additional therapeutic effects across multiple body systems.

Mechanism of Action

  • GLP-1 Receptor Agonism: Slows gastric emptying, reduces appetite, regulates insulin secretion
  • GIP Receptor Agonism: Enhances insulin release, improves glucose tolerance, improves fat metabolism
  • Glucagon Receptor Agonism: Stimulates energy expenditure and promotes fat breakdown (lipolysis)

Clinical Effectiveness

  • Semaglutide (GLP-1 only): 17% average body weight loss after 68 weeks
  • Tirzepatide (GLP-1 + GIP): 24.7% body weight loss after 72 weeks
  • Retatrutide (GLP-1 + GIP + Glucagon):
    • 17.5% average weight loss in just 24 weeks
    • 26.2% average loss in only 48 weeks

This rapid and sustained weight reduction places Retatrutide as the most effective peptide currently being studied for metabolic disorders and fat loss.

Additional Benefits

  • Anti-inflammatory: May assist with autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease.
  • Collagen Support: Promotes epithelialization and collagen synthesis, enhancing skin tone and elasticity.
  • Wound Healing: Accelerates post-injury tissue regeneration
  • Angiogenesis: Encourages the formation of new blood vessels to improve circulation and tissue oxygenation.
  • Muscle Regeneration: Activates satellite cells for muscle growth and repair.

Emerging Therapeutic Applications

Beyond weight loss and glucose control, Retatrutide is being explored for a wide array of research purposes:

  • Cardiovascular Health: May reduce risk factors like hypertension, cholesterol imbalance, and vascular inflammation.
  • Liver Health: Shows promise for reversing non-alcoholic fatty liver disease (NAFLD).
  • Neurological Disorders: Under investigation for Parkinson’s, Alzheimer’s, and other neurodegenerative diseases.
  • Sleep & Addiction: Potential role in treating sleep apnea, substance use disorders, and depression.

An 80 IU smart pen is a reusable, dose-tracking injection device designed to deliver up to 80 international units (IU) of medication. It allows users to dial precise doses in small increments and features safeguards to help prevent dosing errors. Each Smart pen will come with a metal case with 4 x 31G 6mm insulin needles. Once finished you are able to purchase the refill cartridges upon request.

For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use and must not be misused in any way that contravenes MHRA regulations or applicable laws.